Iron isomaltoside 1000
- Generic Name
- Iron isomaltoside 1000
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 1370654-58-2
- Unique Ingredient Identifier
- 3M6325NY1R
- Background
Iron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney Disease, and Anemia, Iron-Deficiency, among others.
- Associated Conditions
- Iron Deficiency (ID), Iron Deficiency Anemia (IDA)
- Associated Therapies
- -
Efficacy of Intravenous Iron Therapy in Maintaining Hemoglobin Concentration on Patients Undergoing Bimaxillary Orthognathic Surgery
- Conditions
- Interventions
- First Posted Date
- 2017-03-29
- Last Posted Date
- 2019-03-20
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 58
- Registration Number
- NCT03094182
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
HiFIT Study : Hip Fracture: Iron and Tranexamic Acid
- Conditions
- Interventions
- First Posted Date
- 2016-11-23
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- University Hospital, Angers
- Target Recruit Count
- 419
- Registration Number
- NCT02972294
- Locations
- 🇫🇷
Chu Grenoble - Departement D'Anesthesie Reanimation, Grenoble, France
🇫🇷CHD Vendée, La Roche-sur-Yon, France
🇫🇷Hospices Civils Lyon, Lyon, France
A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
- Conditions
- Interventions
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2020-11-30
- Lead Sponsor
- Universität des Saarlandes
- Target Recruit Count
- 26
- Registration Number
- NCT02905539
- Locations
- 🇩🇪
Universitätsklinikum des Saarlandes, Homburg, Saarland, Germany
IV Iron Treatment of Restless Legs Syndrome
- Conditions
- Interventions
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2015-06-30
- Lead Sponsor
- Pharmacosmos A/S
- Registration Number
- NCT02484768
A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo
- Conditions
- Interventions
- First Posted Date
- 2014-06-24
- Last Posted Date
- 2016-09-28
- Lead Sponsor
- Pharmacosmos A/S
- Registration Number
- NCT02172001
Iron Replacement in Oesophagogastric Neoplasia
- First Posted Date
- 2013-08-22
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- Nottingham University Hospitals NHS Trust
- Target Recruit Count
- 40
- Registration Number
- NCT01927328
- Locations
- 🇬🇧
Nottingham Univeristy Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom
Treatment of Women After Severe Postpartum Haemorrhage
- Conditions
- Interventions
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 13
- Registration Number
- NCT01895205
Treatment of Women After Postpartum Haemorrhage
- Conditions
- Interventions
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 200
- Registration Number
- NCT01895218
Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia
- Conditions
- Interventions
- First Posted Date
- 2012-06-27
- Last Posted Date
- 2016-08-03
- Lead Sponsor
- Dow University of Health Sciences
- Target Recruit Count
- 271
- Registration Number
- NCT01628770
- Locations
- 🇵🇰
Dow University of Health Sciences, Karachi, Sindh, Pakistan
Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease
- First Posted Date
- 2012-05-16
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 21
- Registration Number
- NCT01599702
- Locations
- 🇩🇰
Pharmacosmos A/S, Hoelbaek, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.